Growth Metrics

Eli Lilly (LLY) Return on Capital Employed (2016 - 2025)

Eli Lilly's Return on Capital Employed history spans 17 years, with the latest figure at 0.37% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 4.0% year-over-year to 0.37%; the TTM value through Dec 2025 reached 0.37%, up 4.0%, while the annual FY2025 figure was 0.48%, 11.0% up from the prior year.
  • Return on Capital Employed reached 0.37% in Q4 2025 per LLY's latest filing, down from 0.38% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.39% in Q2 2025 to a low of 0.19% in Q1 2021.
  • Average Return on Capital Employed over 5 years is 0.28%, with a median of 0.27% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: fell -6bps in 2023, then grew 10bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.22% in 2021, then increased by 17bps to 0.26% in 2022, then rose by 19bps to 0.3% in 2023, then grew by 9bps to 0.33% in 2024, then rose by 12bps to 0.37% in 2025.
  • Per Business Quant, the three most recent readings for LLY's Return on Capital Employed are 0.37% (Q4 2025), 0.38% (Q3 2025), and 0.39% (Q2 2025).